FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004325093> ?p ?o ?g. }

• W2004325093 endingPage "1716" @default.
• W2004325093 startingPage "1716" @default.
• W2004325093 abstract "The delivery of proteins across the blood-brain barrier is severely limited by the proteins' size and biochemical properties. Thus, a large number of peptides have been characterized in recent years that efficaciously prevent neuronal death in vitro, but which may not be applied in vivo, since they are unable to cross cell membrane barriers. In the 1990ies, it had been shown that the HIV TAT protein is able to cross cell membranes even when coupled with larger peptides. Subsequent studies with fusion proteins of the 11-amino acid protein transduction domain of HIV-TAT revealed that TAT fusion proteins may successfully be used for therapeutic purposes in vivo, even when systemically applied. Indeed, intravenous delivery of TAT proteins linked with anti-apoptotic (Bcl-XL) and neurotrophic (GDNF) factors resulted in a rapid and highly efficacious transduction of the brain tissue. When administered after focal cerebral ischemia, intravenous TAT-Bcl-XL and TAT-GDNF significantly reduced brain injury, both when applied after severe and mild ischemic insults. These data provided the first in vivo evidence of the efficacy of fusion proteins in the ischemic brain, thus raising new hopes that neuroprotection is feasible after stroke. Yet, molecular biological studies have pointed out more recently that there are also limitations of the TAT protein strategy, which still need to be addressed. The development of clinically-applicable treatments for ischemic stroke based on fusion protein technologies deserves concerted efforts in the future." @default.
• W2004325093 created "2016-06-24" @default.
• W2004325093 creator A5013141968 @default.
• W2004325093 creator A5028410367 @default.
• W2004325093 creator A5087490218 @default.
• W2004325093 date "2006-01-01" @default.
• W2004325093 modified "2023-10-15" @default.
• W2004325093 title "TAT fusion proteins against ischemic stroke: Current status and future perspectives" @default.
• W2004325093 cites W126490209 @default.
• W2004325093 cites W1506590264 @default.
• W2004325093 cites W1543672481 @default.
• W2004325093 cites W1593489191 @default.
• W2004325093 cites W162141809 @default.
• W2004325093 cites W1796054280 @default.
• W2004325093 cites W1968479682 @default.
• W2004325093 cites W1970914521 @default.
• W2004325093 cites W1974969464 @default.
• W2004325093 cites W1976290510 @default.
• W2004325093 cites W1979379316 @default.
• W2004325093 cites W1979761775 @default.
• W2004325093 cites W1986568749 @default.
• W2004325093 cites W1988078932 @default.
• W2004325093 cites W1992230504 @default.
• W2004325093 cites W1996375992 @default.
• W2004325093 cites W1998903105 @default.
• W2004325093 cites W2001136659 @default.
• W2004325093 cites W2001582257 @default.
• W2004325093 cites W2008576706 @default.
• W2004325093 cites W2020597218 @default.
• W2004325093 cites W2037663553 @default.
• W2004325093 cites W2039702376 @default.
• W2004325093 cites W2040022930 @default.
• W2004325093 cites W2041471383 @default.
• W2004325093 cites W2050942708 @default.
• W2004325093 cites W2052886000 @default.
• W2004325093 cites W2058558306 @default.
• W2004325093 cites W2059779950 @default.
• W2004325093 cites W2076859770 @default.
• W2004325093 cites W2079335891 @default.
• W2004325093 cites W2092108048 @default.
• W2004325093 cites W2145315072 @default.
• W2004325093 cites W250576690 @default.
• W2004325093 cites W8826934 @default.
• W2004325093 cites W962151231 @default.
• W2004325093 doi "https://doi.org/10.2741/1917" @default.
• W2004325093 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16368550" @default.
• W2004325093 hasPublicationYear "2006" @default.
• W2004325093 type Work @default.
• W2004325093 sameAs 2004325093 @default.
• W2004325093 citedByCount "33" @default.
• W2004325093 countsByYear W20043250932012 @default.
• W2004325093 countsByYear W20043250932013 @default.
• W2004325093 countsByYear W20043250932014 @default.
• W2004325093 countsByYear W20043250932015 @default.
• W2004325093 countsByYear W20043250932017 @default.
• W2004325093 countsByYear W20043250932018 @default.
• W2004325093 countsByYear W20043250932020 @default.
• W2004325093 crossrefType "journal-article" @default.
• W2004325093 hasAuthorship W2004325093A5013141968 @default.
• W2004325093 hasAuthorship W2004325093A5028410367 @default.
• W2004325093 hasAuthorship W2004325093A5087490218 @default.
• W2004325093 hasBestOaLocation W20043250931 @default.
• W2004325093 hasConcept C104317684 @default.
• W2004325093 hasConcept C123894998 @default.
• W2004325093 hasConcept C126322002 @default.
• W2004325093 hasConcept C150903083 @default.
• W2004325093 hasConcept C15152581 @default.
• W2004325093 hasConcept C160539049 @default.
• W2004325093 hasConcept C170493617 @default.
• W2004325093 hasConcept C185856081 @default.
• W2004325093 hasConcept C190283241 @default.
• W2004325093 hasConcept C207001950 @default.
• W2004325093 hasConcept C25498285 @default.
• W2004325093 hasConcept C40767141 @default.
• W2004325093 hasConcept C55493867 @default.
• W2004325093 hasConcept C71924100 @default.
• W2004325093 hasConcept C86803240 @default.
• W2004325093 hasConcept C95444343 @default.
• W2004325093 hasConcept C98274493 @default.
• W2004325093 hasConceptScore W2004325093C104317684 @default.
• W2004325093 hasConceptScore W2004325093C123894998 @default.
• W2004325093 hasConceptScore W2004325093C126322002 @default.
• W2004325093 hasConceptScore W2004325093C150903083 @default.
• W2004325093 hasConceptScore W2004325093C15152581 @default.
• W2004325093 hasConceptScore W2004325093C160539049 @default.
• W2004325093 hasConceptScore W2004325093C170493617 @default.
• W2004325093 hasConceptScore W2004325093C185856081 @default.
• W2004325093 hasConceptScore W2004325093C190283241 @default.
• W2004325093 hasConceptScore W2004325093C207001950 @default.
• W2004325093 hasConceptScore W2004325093C25498285 @default.
• W2004325093 hasConceptScore W2004325093C40767141 @default.
• W2004325093 hasConceptScore W2004325093C55493867 @default.
• W2004325093 hasConceptScore W2004325093C71924100 @default.
• W2004325093 hasConceptScore W2004325093C86803240 @default.
• W2004325093 hasConceptScore W2004325093C95444343 @default.
• W2004325093 hasConceptScore W2004325093C98274493 @default.
• W2004325093 hasIssue "1" @default.
• W2004325093 hasLocation W20043250931 @default.

• next